Exclusive use of PowerFlow ports may not be appropriate for all patients

J Clin Apher. 2020 Jan;35(1):66-68. doi: 10.1002/jca.21749. Epub 2019 Sep 18.

Affiliations

¹ Division of Laboratory Medicine, Department of Pathology, The University of Alabama at Birmingham, Birmingham, Alabama.
² Infusion Services, Therapeutic Apheresis, The University of Alabama at Birmingham, Birmingham, Alabama.
³ Department of Laboratory Medicine and Pathology, Mayo Clinic, Phoenix, Arizona.
⁴ Department of Pathology, Keck School of Medicine, University of Southern California, Los Angeles, California.

PMID: 31532839
DOI: 10.1002/jca.21749

No abstract available

Publication types

Letter

MeSH terms

Blood Component Removal / adverse effects
Blood Component Removal / trends
Catheterization, Central Venous / adverse effects*
Catheterization, Central Venous / instrumentation*
Catheterization, Central Venous / trends
Catheters, Indwelling / adverse effects*
Device Approval
Equipment Design
Equipment Failure
Humans